News for 'drug control'

Ministries clash over cap on foreign stakes in drug firms

Ministries clash over cap on foreign stakes in drug firms

Rediff.com28 Nov 2013

The finance ministry is resisting pressure from other departments to cap foreign ownership of domestic drugmakers, fearing such a move would discourage potential investors, a senior ministry source said.

Drug makers told to give pricing details in 10 days

Drug makers told to give pricing details in 10 days

Rediff.com6 Jun 2014

The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.

Another Indian COVID-19 vaccine candidate gets nod for human trial

Another Indian COVID-19 vaccine candidate gets nod for human trial

Rediff.com3 Jul 2020

Zydus plans to initiate the clinical trials of ZyCoV-D in July 2020 across multiple sites in India. In animal studies the vaccine was found to elicit a strong immune response in multiple animal species like mice, rats, guinea pigs and rabbits.

Recruitment for terrorist groups will be treated as terror act: J-K DGP

Recruitment for terrorist groups will be treated as terror act: J-K DGP

Rediff.com18 Nov 2023

He said law enforcement agencies are cracking down on those involved in recruitment for terrorist groups as well as narcotic dealers and smugglers.

9 drug firms may have to gulp Rs 2.5k-cr pill

9 drug firms may have to gulp Rs 2.5k-cr pill

Rediff.com19 Jul 2013

Face NPPA fine for overcharging on anti-asthma drug

WHO meet next week to discuss Covaxin approval

WHO meet next week to discuss Covaxin approval

Rediff.com18 Oct 2021

The World Health Organisation's technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) of Covaxin, a vaccine developed by Hyderabad-based Bharat Biotech protecting against COVID-19, the global health agency's chief scientist said.

Why replacing branded drugs with generics won't be easy

Why replacing branded drugs with generics won't be easy

Rediff.com25 May 2017

Mandatory prescription of generic names is not a complete solution. Rather, in the absence of a range of approaches, it could mean passing the choice of selecting a drug from a doctor to a pharmacist, says Chandrakant Lahariya.

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Rediff.com14 Jun 2021

In the trial, the vaccine will be given by the intramuscular route in two doses on day 0 and day 28.

Venus gets nod for clinical trials

Venus gets nod for clinical trials

Rediff.com14 Jun 2005

Venus Remedies has obtained permission from the Drug Controller General of India for conducting Phase III clinical trials of the new formulation developed by its research and development wing.

How complex is the process of getting approval for a vaccine?

How complex is the process of getting approval for a vaccine?

Rediff.com30 Sep 2020

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.

India acts to repair reputation as drugs exporter

India acts to repair reputation as drugs exporter

Rediff.com7 May 2014

As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.

Serum Institute gets DGCI nod to manufacture Sputnik V in India

Serum Institute gets DGCI nod to manufacture Sputnik V in India

Rediff.com4 Jun 2021

The Drugs Controller General of India (DCGI) has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said.

Drug prices likely to rise by 6%

Drug prices likely to rise by 6%

Rediff.com22 Jan 2005

Why terrorists are active in Rajouri-Poonch belt

Why terrorists are active in Rajouri-Poonch belt

Rediff.com22 Dec 2023

Security and defence experts have called for immediate strengthening of the security management and intelligence network along the Line of Control (LoC) in Jammu region, which witnessed the killing of 59 people, including 24 security personnel and 28 terrorists, in terror incidents this year.

Will be able to supply 10 cr Covishield doses in June: Serum

Will be able to supply 10 cr Covishield doses in June: Serum

Rediff.com30 May 2021

In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic.

Serum Institute ready to roll out Covid vaccine

Serum Institute ready to roll out Covid vaccine

Rediff.com3 Jan 2021

The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.

Mumbai court allows return of Aryan Khan's passport

Mumbai court allows return of Aryan Khan's passport

Rediff.com14 Jul 2022

Aryan Khan had submitted his passport before the court as part of his bail conditions.

Former Brazil, Inter striker Adriano charged with links to Rio drug lord

Former Brazil, Inter striker Adriano charged with links to Rio drug lord

Rediff.com6 Nov 2014

Former Brazil football international Adriano has reportedly been charged with links to a drug lord in Rio de Janeiro.

Liquid drugs put under price cap

Liquid drugs put under price cap

Rediff.com4 Feb 2008

The move brings an additional 15 per cent of the retail medicine market worth over Rs 4,000 crore (Rs 40 billion) under direct price control. All domestic companies, including drug majors like Ranbaxy, Cipla, Lupin and Dr Reddy's, have syrups and tonics in their product portfolio.

Expert panel seeks more data on SII, Bharat Biotech vaccines

Expert panel seeks more data on SII, Bharat Biotech vaccines

Rediff.com10 Dec 2020

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.

New drug policy, regulations slowing down pharma growth

New drug policy, regulations slowing down pharma growth

Rediff.com31 Oct 2013

Hit by the new drug pricing policy and regulatory interventions, growth rate of the Rs 72,069-crore Indian pharmaceutical market has slowed down to 9.8 per cent in 2013 as compared to 16.6 per cent in 2012, says a report.

US agency to assist NCB drug probe

US agency to assist NCB drug probe

Rediff.com26 May 2003

India battles HIV/AIDS drug shortage as some firms halt supply

India battles HIV/AIDS drug shortage as some firms halt supply

Rediff.com4 Sep 2014

India had the third-largest number of people living with HIV in the world at the end of 2013 and accounts for about four out of 10 people living with HIV in the Asian region.

« Prev  |